Egr1 regulates lithium-induced transcription of the Period 2 (PER2) gene

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 12, 2013, Pages 1969-1979

  Kim, Se Hyun ^a   Yu, Hyun Sook ^b   Park, Hong Guen ^b   Ahn, Yong Min ^a,b   Kim, Yong Sik ^c   Lee, Young Han ^d,e   Ha, Kyooseob ^a,b,f   Shin, Soon Young ^d,e  

^a Seoul National University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Dongguk University Ilsan Hospital   (South Korea)

^d Konkuk University   (South Korea)

^e Konkuk University Hospital   (South Korea)

^f Seoul National University Bundang Hospital   (South Korea)

Author keywords

Bipolar disorder; Circadian gene; Egr1; Lithium; Mood stabilizer; Per2

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; LITHIUM; MITOGEN ACTIVATED PROTEIN KINASE 1; PER2 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BIPOLAR DISORDER; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DRUG EFFECT; FRONTAL CORTEX; GEL MOBILITY SHIFT ASSAY; GENOMIC FRAGMENT; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGHT DARK CYCLE; MALE; MOUSE; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA CELL; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TRANSIENT TRANSFECTION;

EID: 84882781735     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.06.010     Document Type: Article

References (96)

1. Reppert S.M., Weaver D.R. Coordination of circadian timing in mammals. Nature 2002, 418:935-941.
2. Balsalobre A. Clock genes in mammalian peripheral tissues. Cell Tissue Res. 2002, 309:193-199.
3. Gery S., Koeffler H.P. Circadian rhythms and cancer. Cell Cycle 2010, 9:1097-1103.
4. Huang W., Ramsey K.M., Marcheva B., Bass J. Circadian rhythms, sleep, and metabolism. J. Clin. Invest. 2011, 121:2133-2141.
5. Rosenwasser A.M. Circadian clock genes: non-circadian roles in sleep, addiction, and psychiatric disorders?. Neurosci. Biobehav. Rev. 2010, 34:1249-1255.
6. Masubuchi S., Honma S., Abe H., Ishizaki K., Namihira M., Ikeda M., Honma K. Clock genes outside the suprachiasmatic nucleus involved in manifestation of locomotor activity rhythm in rats. Eur. J. Neurosci. 2000, 12:4206-4214.
7. Rath M.F., Rohde K., Fahrenkrug J., Moller M. Circadian clock components in the rat neocortex: daily dynamics, localization and regulation. Brain Struct. Funct. 2013, 218:551-562.
8. Shieh K.R. Distribution of the rhythm-related genes rPERIOD1, rPERIOD2, and rCLOCK, in the rat brain. Neuroscience 2003, 118:831-843.
9. Lamont E.W., Legault-Coutu D., Cermakian N., Boivin D.B. The role of circadian clock genes in mental disorders. Dialogues Clin. Neurosci. 2007, 9:333-342.
10. McClung C.A. Circadian genes, rhythms and the biology of mood disorders. Pharmacol. Ther. 2007, 114:222-232.
11. Matsui D., Takekida S., Okamura H. Molecular oscillation of Per1 and Per2 genes in the rodent brain: an in situ hybridization and molecular biological study. Kobe J. Med. Sci. 2005, 51:85-93.
12. Zhang E.E., Kay S.A. Clocks not winding down: unravelling circadian networks. Nat. Rev. Mol. Cell Biol. 2010, 11:764-776.
13. Hastings M.H., Reddy A.B., Maywood E.S. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat. Rev. Neurosci. 2003, 4:649-661.
14. Dunlap J.C. Molecular bases for circadian clocks. Cell 1999, 96:271-290.
15. Gekakis N., Staknis D., Nguyen H.B., Davis F.C., Wilsbacher L.D., King D.P., Takahashi J.S., Weitz C.J. Role of the CLOCK protein in the mammalian circadian mechanism. Science 1998, 280:1564-1569.
16. Jin X., Shearman L.P., Weaver D.R., Zylka M.J., de Vries G.J., Reppert S.M. A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock. Cell 1999, 96:57-68.
17. Kume K., Zylka M.J., Sriram S., Shearman L.P., Weaver D.R., Jin X., Maywood E.S., Hastings M.H., Reppert S.M. mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell 1999, 98:193-205.
18. Gallego M., Virshup D.M. Post-translational modifications regulate the ticking of the circadian clock. Nat. Rev. Mol. Cell Biol. 2007, 8:139-148.
19. Kripke D.F., Mullaney D.J., Atkinson M., Wolf S. Circadian rhythm disorders in manic-depressives. Biol. Psychiatry 1978, 13:335-351.
20. Mansour H.A., Wood J., Chowdari K.V., Dayal M., Thase M.E., Kupfer D.J., Monk T.H., Devlin B., Nimgaonkar V.L. Circadian phase variation in bipolar I disorder. Chronobiol. Int. 2005, 22:571-584.
21. Kripke D.F., Nievergelt C.M., Joo E., Shekhtman T., Kelsoe J.R. Circadian polymorphisms associated with affective disorders. J. Circadian Rhythms 2009, 7:2.
22. Mansour H.A., Talkowski M.E., Wood J., Chowdari K.V., McClain L., Prasad K., Montrose D., Fagiolini A., Friedman E.S., Allen M.H., Bowden C.L., Calabrese J., El-Mallakh R.S., Escamilla M., Faraone S.V., Fossey M.D., Gyulai L., Loftis J.M., Hauser P., Ketter T.A., Marangell L.B., Miklowitz D.J., Nierenberg A.A., Patel J., Sachs G.S., Sklar P., Smoller J.W., Laird N., Keshavan M., Thase M.E., Axelson D., Birmaher B., Lewis D., Monk T., Frank E., Kupfer D.J., Devlin B., Nimgaonkar V.L. Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord. 2009, 11:701-710.
23. Mansour H.A., Wood J., Logue T., Chowdari K.V., Dayal M., Kupfer D.J., Monk T.H., Devlin B., Nimgaonkar V.L. Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia. Genes Brain Behav. 2006, 5:150-157.
24. Nievergelt C.M., Kripke D.F., Barrett T.B., Burg E., Remick R.A., Sadovnick A.D., McElroy S.L., Keck P.E., Schork N.J., Kelsoe J.R. Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006, 141B:234-241.
25. Podawiltz A. A review of current bipolar disorder treatment guidelines. J. Clin. Psychiatry 2012, 73:e12.
26. Yatham L.N., Kennedy S.H., Parikh S.V., Schaffer A., Beaulieu S., Alda M., O'Donovan C., Macqueen G., McIntyre R.S., Sharma V., Ravindran A., Young L.T., Milev R., Bond D.J., Frey B.N., Goldstein B.I., Lafer B., Birmaher B., Ha K., Nolen W.A., Berk M. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord. 2013, 15:1-44.
27. Schulze T.G., Alda M., Adli M., Akula N., Ardau R., Bui E.T., Chillotti C., Cichon S., Czerski P., Del Zompo M., Detera-Wadleigh S.D., Grof P., Gruber O., Hashimoto R., Hauser J., Hoban R., Iwata N., Kassem L., Kato T., Kittel-Schneider S., Kliwicki S., Kelsoe J.R., Kusumi I., Laje G., Leckband S.G., Manchia M., Macqueen G., Masui T., Ozaki N., Perlis R.H., Pfennig A., Piccardi P., Richardson S., Rouleau G., Reif A., Rybakowski J.K., Sasse J., Schumacher J., Severino G., Smoller J.W., Squassina A., Turecki G., Young L.T., Yoshikawa T., Bauer M., McMahon F.J. The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology 2010, 62:72-78.
28. Johnsson A., Engelmann W., Pflug B., Klemke W. Period lengthening of human circadian rhythms by lithium carbonate, a prophylactic for depressive disorders. Int. J. Chronobiol. 1983, 8:129-147.
29. Li J., Lu W.Q., Beesley S., Loudon A.S., Meng Q.J. Lithium impacts on the amplitude and period of the molecular circadian clockwork. PLoS One 2012, 7:e33292.
30. Iitaka C., Miyazaki K., Akaike T., Ishida N. A role for glycogen synthase kinase-3beta in the mammalian circadian clock. J. Biol. Chem. 2005, 280:29397-29402.
31. Osland T.M., Ferno J., Havik B., Heuch I., Ruoff P., Laerum O.D., Steen V.M. Lithium differentially affects clock gene expression in serum-shocked NIH-3T3 cells. J. Psychopharmacol. 2011, 25:924-933.
32. Johansson A.S., Brask J., Owe-Larsson B., Hetta J., Lundkvist G.B. Valproic acid phase shifts the rhythmic expression of Period2::Luciferase. J. Biol. Rhythms 2011, 26:541-551.
33. McQuillin A., Rizig M., Gurling H.M. A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder. Pharmacogenet. Genomics 2007, 17:605-617.
34. Lee H.J., Khoshaghideh F., Patel S., Lee S.J. Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway. J. Neurosci. 2004, 24:1888-1896.
35. Lee S.L., Wang Y., Milbrandt J. Unimpaired macrophage differentiation and activation in mice lacking the zinc finger transplantation factor NGFI-A (EGR1). Mol. Cell. Biol. 1996, 16:4566-4572.
36. Shin S.Y., Song H., Kim C.G., Choi Y.K., Lee K.S., Lee S.J., Lee H.J., Lim Y., Lee Y.H. Egr-1 is necessary for fibroblast growth factor-2-induced transcriptional activation of the glial cell line-derived neurotrophic factor in murine astrocytes. J. Biol. Chem. 2009, 284:30583-30593.
37. Longoni R., Spina L., Vinci S., Acquas E. The MEK inhibitor SL327 blocks acquisition but not expression of lithium-induced conditioned place aversion: a behavioral and immunohistochemical study. Psychopharmacology (Berl) 2011, 216:63-73.
38. Armani F., Andersen M.L., Andreatini R., Frussa-Filho R., Tufik S., Galduroz J.C. Successful combined therapy with tamoxifen and lithium in a paradoxical sleep deprivation-induced mania model. CNS Neurosci. Ther. 2012, 18:119-125.
39. Gould T.D., O'Donnell K.C., Picchini A.M., Manji H.K. Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium. Neuropsychopharmacology 2007, 32:1321-1333.
40. Gould T.J., Keith R.A., Bhat R.V. Differential sensitivity to lithium's reversal of amphetamine-induced open-field activity in two inbred strains of mice. Behav. Brain Res. 2001, 118:95-105.
41. Sabioni P., Baretta I.P., Ninomiya E.M., Gustafson L., Rodrigues A.L., Andreatini R. The antimanic-like effect of tamoxifen: Behavioural comparison with other PKC-inhibiting and antiestrogenic drugs. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1927-1931.
42. Berggren U., Tallstedt L., Ahlenius S., Engel J. The effect of lithium on amphetamine-induced locomotor stimulation. Psychopharmacology (Berl) 1978, 59:41-45.
43. Morrison J.M., Pritchard H.D., Braude M.C., D'Aguanno W. Plasma and brain lithium levels after lithium carbonate and lithium chloride administration by different routes in rats. Proc. Soc. Exp. Biol. Med. 1971, 137:889-892.
44. Aicher W.K., Sakamoto K.M., Hack A., Eibel H. Analysis of functional elements in the human Egr-1 gene promoter. Rheumatol. Int. 1999, 18:207-214.
45. Russo M.W., Matheny C., Milbrandt J. Transcriptional activity of the zinc finger protein NGFI-A is influenced by its interaction with a cellular factor. Mol. Cell. Biol. 1993, 13:6858-6865.
46. Kim S.H., Seo M.S., Jeon W.J., Yu H.S., Park H.G., Jung G.A., Lee H.Y., Kang U.G., Kim Y.S. Haloperidol regulates the phosphorylation level of the MEK-ERK-p90RSK signal pathway via protein phosphatase 2A in the rat frontal cortex. Int. J. Neuropsychopharmacol. 2008, 11:509-517.
47. Mai L., Jope R.S., Li X. BDNF-mediated signal transduction is modulated by GSK3beta and mood stabilizing agents. J. Neurochem. 2002, 82:75-83.
48. Shin S.Y., Kim J.H., Lee J.H., Lim Y., Lee Y.H. 2'-Hydroxyflavanone induces apoptosis through Egr-1 involving expression of Bax, p21, and NAG-1 in colon cancer cells. Mol. Nutr. Food Res. 2012, 56:761-774.
49. Choi B.H., Kim C.G., Bae Y.S., Lim Y., Lee Y.H., Shin S.Y. p21 Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression. Cancer Res. 2008, 68:1369-1377.
50. Williams R.S., Harwood A.J. Lithium therapy and signal transduction. Trends Pharmacol. Sci. 2000, 21:61-64.
51. Kim C.G., Choi B.H., Son S.W., Yi S.J., Shin S.Y., Lee Y.H. Tamoxifen-induced activation of p21Waf1/Cip1 gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells. Cell. Signal. 2007, 19:1290-1300.
52. Lim C.P., Jain N., Cao X. Stress-induced immediate-early gene, egr-1, involves activation of p38/JNK1. Oncogene 1998, 16:2915-2926.
53. Cohen D.M. Urea-inducible Egr-1 transcription in renal inner medullary collecting duct (mIMCD3) cells is mediated by extracellular signal-regulated kinase activation. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:11242-11247.
54. Yang S.H., Sharrocks A.D. Convergence of the SUMO and MAPK pathways on the ETS-domain transcription factor Elk-1. Biochem. Soc. Symp. 2006, 121-129.
55. Ling Y., Lakey J.H., Roberts C.E., Sharrocks A.D. Molecular characterization of the B-box protein-protein interaction motif of the ETS-domain transcription factor Elk-1. EMBO J. 1997, 16:2431-2440.
56. Watson D.K., Robinson L., Hodge D.R., Kola I., Papas T.S., Seth A. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements. Oncogene 1997, 14:213-221.
57. Kinoshita C., Miyazaki K., Ishida N. Chronic stress affects PERIOD2 expression through glycogen synthase kinase-3beta phosphorylation in the central clock. Neuroreport 2012, 23:98-102.
58. Reick M., Garcia J.A., Dudley C., McKnight S.L. NPAS2: an analog of clock operative in the mammalian forebrain. Science 2001, 293:506-509.
59. Koyanagi S., Hamdan A.M., Horiguchi M., Kusunose N., Okamoto A., Matsunaga N., Ohdo S. cAMP-response element (CRE)-mediated transcription by activating transcription factor-4 (ATF4) is essential for circadian expression of the Period2 gene. J. Biol. Chem. 2011, 286:32416-32423.
60. Shimizu F., Fukada Y. Circadian phosphorylation of ATF-2, a potential activator of Period2 gene transcription in the chick pineal gland. J. Neurochem. 2007, 103:1834-1842.
61. Ohno T., Onishi Y., Ishida N. The negative transcription factor E4BP4 is associated with circadian clock protein PERIOD2. Biochem. Biophys. Res. Commun. 2007, 354:1010-1015.
62. Wirz-Justice A. Biological rhythm disturbances in mood disorders. Int. Clin. Psychopharmacol. 2006, 21(Suppl. 1):S11-S15.
63. Lewy A.J. Depressive disorders may more commonly be related to circadian phase delays rather than advances: time will tell. Sleep Med. 2010, 11:117-118.
64. Klemfuss H. Rhythms and the pharmacology of lithium. Pharmacol. Ther. 1992, 56:53-78.
65. Knapska E., Kaczmarek L. A gene for neuronal plasticity in the mammalian brain: Zif268/Egr-1/NGFI-A/Krox-24/TIS8/ZENK?. Prog. Neurobiol. 2004, 74:183-211.
66. James A.B., Conway A.M., Morris B.J. Regulation of the neuronal proteasome by Zif268 (Egr1). J. Neurosci. 2006, 26:1624-1634.
67. Baumgartel K., Genoux D., Welzl H., Tweedie-Cullen R.Y., Koshibu K., Livingstone-Zatchej M., Mamie C., Mansuy I.M. Control of the establishment of aversive memory by calcineurin and Zif268. Nat. Neurosci. 2008, 11:572-578.
68. Fustin J.M., Dardente H., Wagner G.C., Carter D.A., Johnston J.D., Lincoln G.A., Hazlerigg D.G. Egr1 involvement in evening gene regulation by melatonin. FASEB J. 2009, 23:764-773.
69. Resuehr H.E., Resuehr D., Olcese J. Induction of mPer1 expression by GnRH in pituitary gonadotrope cells involves EGR-1. Mol. Cell. Endocrinol. 2009, 311:120-125.
70. Aronin N., Sagar S.M., Sharp F.R., Schwartz W.J. Light regulates expression of a Fos-related protein in rat suprachiasmatic nuclei. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:5959-5962.
71. Kornhauser J.M., Nelson D.E., Mayo K.E., Takahashi J.S. Photic and circadian regulation of c-fos gene expression in the hamster suprachiasmatic nucleus. Neuron 1990, 5:127-134.
72. Kornhauser J.M., Nelson D.E., Mayo K.E., Takahashi J.S. Regulation of jun-B messenger RNA and AP-1 activity by light and a circadian clock. Science 1992, 255:1581-1584.
73. Rusak B., Robertson H.A., Wisden W., Hunt S.P. Light pulses that shift rhythms induce gene expression in the suprachiasmatic nucleus. Science 1990, 248:1237-1240.
74. Kilduff T.S., Vugrinic C., Lee S.L., Milbrandt J.D., Mikkelsen J.D., O'Hara B.F., Heller H.C. Characterization of the circadian system of NGFI-A and NGFI-A/NGFI-B deficient mice. J. Biol. Rhythms 1998, 13:347-357.
75. Einat H., Yuan P., Gould T.D., Li J., Du J., Zhang L., Manji H.K., Chen G. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J. Neurosci. 2003, 23:7311-7316.
76. Antle M.C., Kriegsfeld L.J., Silver R. Signaling within the master clock of the brain: localized activation of mitogen-activated protein kinase by gastrin-releasing peptide. J. Neurosci. 2005, 25:2447-2454.
77. Mateju K., Bendova Z., El-Hennamy R., Sladek M., Sosniyenko S., Sumova A. Development of the light sensitivity of the clock genes Period1 and Period2, and immediate-early gene c-fos within the rat suprachiasmatic nucleus. Eur. J. Neurosci. 2009, 29:490-501.
78. Antoun G., Cannon P.B., Cheng H.Y. Regulation of MAPK/ERK signaling and photic entrainment of the suprachiasmatic nucleus circadian clock by Raf kinase inhibitor protein. J. Neurosci. 2012, 32:4867-4877.
79. Dziema H., Oatis B., Butcher G.Q., Yates R., Hoyt K.R., Obrietan K. The ERK/MAP kinase pathway couples light to immediate-early gene expression in the suprachiasmatic nucleus. Eur. J. Neurosci. 2003, 17:1617-1627.
80. Eckel-Mahan K.L., Phan T., Han S., Wang H., Chan G.C., Scheiner Z.S., Storm D.R. Circadian oscillation of hippocampal MAPK activity and cAmp: implications for memory persistence. Nat. Neurosci. 2008, 11:1074-1082.
81. Phan T.X., Chan G.C., Sindreu C.B., Eckel-Mahan K.L., Storm D.R. The diurnal oscillation of MAP (mitogen-activated protein) kinase and adenylyl cyclase activities in the hippocampus depends on the suprachiasmatic nucleus. J. Neurosci. 2011, 31:10640-10647.
82. Nomura K., Takeuchi Y., Fukunaga K. MAP kinase additively activates the mouse Per1 gene promoter with CaM kinase II. Brain Res. 2006, 1118:25-33.
83. Miyamura N., Hirayama J., Sawanobori K., Tamaru T., Asaoka Y., Honda R., Yamamoto T., Uno H., Takamatsu K., Nishina H. CLOCK:BMAL-independent circadian oscillation of zebrafish Cryptochrome1a gene. Biol. Pharm. Bull. 2009, 32:1183-1187.
84. Sugimoto T., Morioka N., Sato K., Hisaoka K., Nakata Y. Noradrenergic regulation of period1 expression in spinal astrocytes is involved in protein kinase A, c-Jun N-terminal kinase and extracellular signal-regulated kinase activation mediated by alpha1- and beta2-adrenoceptors. Neuroscience 2011, 185:1-13.
85. Bae K., Jin X., Maywood E.S., Hastings M.H., Reppert S.M., Weaver D.R. Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. Neuron 2001, 30:525-536.
86. Pantazopoulos H., Dolatshad H., Davis F.C. A fear-inducing odor alters PER2 and c-Fos expression in brain regions involved in fear memory. PLoS One 2011, 6:e20658.
87. Wang L.M., Dragich J.M., Kudo T., Odom I.H., Welsh D.K., O'Dell T.J., Colwell C.S. Expression of the circadian clock gene Period2 in the hippocampus: possible implications for synaptic plasticity and learned behaviour. ASN Neuro 2009, 1.
88. Koresh O., Kozlovsky N., Kaplan Z., Zohar J., Matar M.A., Cohen H. The long-term abnormalities in circadian expression of Period 1 and Period 2 genes in response to stress is normalized by agomelatine administered immediately after exposure. Eur. Neuropsychopharmacol. 2012, 22:205-221.
89. Uz T., Ahmed R., Akhisaroglu M., Kurtuncu M., Imbesi M., Dirim Arslan A., Manev H. Effect of fluoxetine and cocaine on the expression of clock genes in the mouse hippocampus and striatum. Neuroscience 2005, 134:1309-1316.
90. Hood S., Cassidy P., Mathewson S., Stewart J., Amir S. Daily morphine injection and withdrawal disrupt 24-h wheel running and PERIOD2 expression patterns in the rat limbic forebrain. Neuroscience 2011, 186:65-75.
91. Spanagel R., Pendyala G., Abarca C., Zghoul T., Sanchis-Segura C., Magnone M.C., Lascorz J., Depner M., Holzberg D., Soyka M., Schreiber S., Matsuda F., Lathrop M., Schumann G., Albrecht U. The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat. Med. 2005, 11:35-42.
92. Abarca C., Albrecht U., Spanagel R. Cocaine sensitization and reward are under the influence of circadian genes and rhythm. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:9026-9030.
93. Fu L., Pelicano H., Liu J., Huang P., Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002, 111:41-50.
94. Borgs L., Beukelaers P., Vandenbosch R., Nguyen L., Moonen G., Maquet P., Albrecht U., Belachew S., Malgrange B. Period 2 regulates neural stem/progenitor cell proliferation in the adult hippocampus. BMC Neurosci. 2009, 10:30.
95. Price J.L., Drevets W.C. Neural circuits underlying the pathophysiology of mood disorders. Trends Cogn. Sci. 2012, 16:61-71.
96. Myers-Schulz B., Koenigs M. Functional anatomy of ventromedial prefrontal cortex: implications for mood and anxiety disorders. Mol. Psychiatry 2012, 17:132-141.